Corbus Pharmaceuticals Holdings (CRBP) Short term Debt (2013 - 2024)
Corbus Pharmaceuticals Holdings (CRBP) recorded quarterly Short term Debt of $10882.0 in Q1 2024, down 72.1% quarter-over-quarter from $39000.0 in Q4 2023, and down 99.78% on a YoY basis from $5.0 million in Q2 2023.
Corbus Pharmaceuticals Holdings (CRBP) Short term Debt (2013 - 2024) Analysis & Trends
Corbus Pharmaceuticals Holdings' Short term Debt history runs 7 years deep, the most recent figure standing at $10882.0 for Q1 2024.
- In Q1 2024, Short term Debt fell 99.78% year-over-year to $10882.0; the TTM figure through Mar 2024 stood at $10882.0 (down 99.78% YoY), while the FY2023 annual figure was $39000.0, down 98.6% from the prior year.
- Short term Debt was $10882.0 for Q1 2024 at Corbus Pharmaceuticals Holdings, down from $39000.0 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $9.9 million in Q3 2022 to a low of $10882.0 in Q1 2024.
- Historically, Short term Debt has averaged $2.0 million across 5 years, with a median of $757000.0 in 2020.
- The sharpest annual moves came in 2022 and 2024: Short term Debt surged 7691.16% in 2022, then sank 99.78% in 2024.
- A 5-year view of Short term Debt shows it stood at $797000.0 in 2020, then surged by 288.12% to $3.1 million in 2021, then decreased by 9.62% to $2.8 million in 2022, then slumped by 98.6% to $39000.0 in 2023, then plunged by 72.1% to $10882.0 in 2024.
- The last three Short term Debt figures came in at $10882.0 (Q1 2024), $39000.0 (Q4 2023), and $36868.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Corbus Pharmaceuticals Holdings | 133.67 Mn | 105.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 10,882.00 |
| Dec 31, 2023 | 39,000.00 |
| Sep 30, 2023 | 36,868.00 |
| Jun 30, 2023 | 36,868.00 |
| Mar 31, 2023 | 5.01 Mn |
| Dec 31, 2022 | 2.80 Mn |
| Sep 30, 2022 | 9.88 Mn |
| Jun 30, 2022 | 133,710.00 |
| Mar 31, 2022 | 5.18 Mn |
| Dec 31, 2021 | 3.09 Mn |
| Sep 30, 2021 | 126,857.00 |
| Jun 30, 2021 | 599,000.00 |
| Mar 31, 2021 | 803,000.00 |
| Dec 31, 2020 | 797,000.00 |
| Sep 30, 2020 | 757,000.00 |
| Jun 30, 2014 | 18,414.00 |
| Dec 31, 2013 | 19,932.00 |
| Sep 30, 2013 | 21,910.00 |